Pulsed field ablation: from technological breakthrough to structured clinical implementation—the role of the European Heart Rhythm Association
Europace · 30.03.2026 · 28 (4)
DOI: 10.1093/europace/euag074 ↗Kurz gefasst
Fachartikel in der Zeitschrift Europace, online erschienen am 12.04.2026. Verfasst von Helmut Pürerfellner und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Ordensklinikum Linz Elisabethinen, Linz, Austria. Hauptthemen laut MEDLINE: Atrial Fibrillation, Cardiology, Irreversible Electroporation Therapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Pulsed field ablation (PFA) has rapidly evolved from an experimental electroporation-based concept to a widely adopted modality in cardiac electrophysiology, marking one of the fastest clinical integrations of a novel technology in the field. Its non-thermal mechanism, based on irreversible electroporation, fundamentally distinguishes it from conventional radiofrequency and cryoablation, providing relative myocardial selectivity and driving widespread enthusiasm and clinical uptake. However, the rapid expansion of PFA into routine practice introduces new clinical and organizational challenges. The growing number of scientific statements reflects the dynamic evolution of PFA technologies and underscores the need for iterative, regionally relevant guidance. Variability in healthcare systems, procedural workflows, and resource availability further necessitates tailored guidance, particularly within the European context. As the field transitions from innovation to implementation, emphasis must shift towards standardized procedural strategies, avoidance of excessive ablation, and structured education. Training programmes must incorporate electroporation-specific principles and safety management. Ultimately, the responsible integration of PFA requires continued vigilance, registry-based surveillance, and collaborative scientific leadership. Ensuring that rapid technological progress translates into consistent, safe, and effective patient care remains a central priority for the European Heart Rhythm Association.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Ordensklinikum Linz Elisabethinen, Linz, Austria.
- La Paz University Hospital Research Institute (IdiPAZ), Universidad Autónoma de Madrid, Madrid, Spain.
- Cardiology Department, University Hospital of Geneva, Geneva, Switzerland.
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Via del Pozzo 71, 41124 Modena, Italy.
- Department of Cardiology, University Hospital Basel, Basel, Switzerland.
ORCID-Profile: Helmut Pürerfellner, Jose Luis Merino, Haran Burri, Giuseppe Boriani, Michael Kühne
Zitieren
APA
Pürerfellner, H., Merino, J. L., Burri, H., Boriani, G., & Kühne, M. (2026). Pulsed field ablation: from technological breakthrough to structured clinical implementation—the role of the European Heart Rhythm Association. Europace, 28(4). https://doi.org/10.1093/europace/euag074
Vancouver
Pürerfellner H, Merino JL, Burri H, Boriani G, Kühne M. Pulsed field ablation: from technological breakthrough to structured clinical implementation—the role of the European Heart Rhythm Association. Europace. 2026;28(4). doi:10.1093/europace/euag074
BibTeX
@article{Prerfellner2026,
author = {Pürerfellner, Helmut and Merino, Jose Luis and Burri, Haran and Boriani, Giuseppe and Kühne, Michael},
title = {Pulsed field ablation: from technological breakthrough to structured clinical implementation—the role of the European Heart Rhythm Association},
journal = {Europace},
year = {2026},
volume = {28},
number = {4},
doi = {10.1093/europace/euag074}
}
EUVIMED